Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1

Status

Unknown 9Completed 6Recruiting 4Not yet recruiting 3Terminated 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Stomach Neoplasms 3Pancreatic Neoplasms 1HER2-positive Gastric Cancer 1Efficacy and Safety 1

Interventions

Oxaliplatin 14sintilimab 10S 1 (combination) 9Drug Therapy 7Capecitabine 5tislelizumab 4Surgical Procedures, Operative 4Paclitaxel 4HMPL-013 4apatinib 3Tegafur 3Immune Checkpoint Inhibitors 3Cisplatin 3Bevacizumab 3surufatinib 2potassium oxonate 2lenvatinib 2irinotecan sucrosofate 2gimeracil 2Observation 2Injections 2Hyperthermic Intraperitoneal Chemotherapy 2Fluorouracil 2Exercise 2Endoscopic Mucosal Resection 2Doxorubicin 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2zolbetuximab 1toripalimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Stomach Neoplasms × Tegafur × Clear all
NCT06603974 2024-09-19

EASOBFGE

Xijing Hospital

Phase NA Not yet recruiting
48 enrolled
Gastrointestinal

Stomach Neoplasms

NCT05498766 2024-06-24

Effect and Safety of Huaier Granule Versus SOX Regimen in Gastric Cancer Patients

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 4 Not yet recruiting
702 enrolled
Gastrointestinal

Stomach Neoplasms

NCT05914610 2023-08-25

Envollizumab Combined With Fruquintinib and SOX Versus SOX for Conversion Therapy in Advanced Gastric Cancer

Fujian Medical University

Phase 3 Not yet recruiting
100 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡